Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary ...

Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...